Pierre Jacob

1.3k total citations
27 papers, 938 citations indexed

About

Pierre Jacob is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Pierre Jacob has authored 27 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 8 papers in Neurology. Recurrent topics in Pierre Jacob's work include Genetic Neurodegenerative Diseases (6 papers), Mitochondrial Function and Pathology (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Pierre Jacob is often cited by papers focused on Genetic Neurodegenerative Diseases (6 papers), Mitochondrial Function and Pathology (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Pierre Jacob collaborates with scholars based in Canada, France and United States. Pierre Jacob's co-authors include Peter Humphreys, Robert G. Korneluk, Alasdair G. W. Hunter, Gabrielle Mettler, Linda Surh, Catherine Tsilfidis, Mani S. Mahadevan, Daniel L. Keene, Craig Campbell and Craig Campbell and has published in prestigious journals such as Neurology, PEDIATRICS and The American Journal of Cardiology.

In The Last Decade

Pierre Jacob

27 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Jacob Canada 16 429 368 234 143 122 27 938
Craig Campbell Canada 22 720 1.7× 338 0.9× 213 0.9× 152 1.1× 114 0.9× 90 1.3k
Paula Bray Australia 15 324 0.8× 186 0.5× 78 0.3× 128 0.9× 104 0.9× 47 1.0k
Henry B. Wessel United States 16 317 0.7× 194 0.5× 103 0.4× 137 1.0× 76 0.6× 23 781
Martin Kirkpatrick United Kingdom 13 341 0.8× 318 0.9× 108 0.5× 290 2.0× 82 0.7× 33 984
Sotiris Youroukos Greece 16 327 0.8× 244 0.7× 187 0.8× 289 2.0× 124 1.0× 33 899
Christian von der Brelie Germany 18 200 0.5× 401 1.1× 468 2.0× 119 0.8× 53 0.4× 58 1.1k
John H. N. Deck Canada 18 188 0.4× 505 1.4× 522 2.2× 171 1.2× 50 0.4× 35 1.4k
Pierre J. Vinken Netherlands 12 238 0.6× 264 0.7× 370 1.6× 156 1.1× 77 0.6× 37 1.1k
Raphael Weitz Israel 19 160 0.4× 130 0.4× 197 0.8× 214 1.5× 76 0.6× 56 879
Federica Zibordi Italy 21 283 0.7× 219 0.6× 403 1.7× 150 1.0× 131 1.1× 51 1.1k

Countries citing papers authored by Pierre Jacob

Since Specialization
Citations

This map shows the geographic impact of Pierre Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Jacob more than expected).

Fields of papers citing papers by Pierre Jacob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Jacob. The network helps show where Pierre Jacob may publish in the future.

Co-authorship network of co-authors of Pierre Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Jacob. A scholar is included among the top collaborators of Pierre Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Jacob. Pierre Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacob, Pierre, Isabelle Desmoulins, Sylvie Zanetta, et al.. (2024). Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience. Cancers. 16(2). 280–280. 1 indexed citations
2.
Vanhersecke, Lucile, Pierre Jacob, Ludovic Gillet, et al.. (2024). 1779P Deep learning tertiary lymphoid structures detection on HES/H&E slides and association to survival outcome in sarcoma. Annals of Oncology. 35. S1058–S1058. 1 indexed citations
3.
Campbell, Craig, Simon A. Levin, Victoria Mok Siu, Shannon L. Venance, & Pierre Jacob. (2013). Congenital Myotonic Dystrophy: Canadian Population-Based Surveillance Study. The Journal of Pediatrics. 163(1). 120–125.e3. 45 indexed citations
4.
Sbrocchi, Anne Marie, Frank Rauch, Pierre Jacob, et al.. (2012). The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy. Osteoporosis International. 23(11). 2703–2711. 95 indexed citations
5.
McMillan, Hugh J., Melissa T. Carter, Pierre Jacob, et al.. (2009). Homozygous contiguous gene deletion of 13q12 causing LGMD2C and ARSACS in the same patient. Muscle & Nerve. 39(3). 396–399. 11 indexed citations
6.
Mineyko, Aleksandra & Pierre Jacob. (2008). Case 2: Long-standing neuropathy with acute onset of weakness. Paediatrics & Child Health. 13(2). 121–123. 1 indexed citations
7.
8.
Keene, Daniel L., Ian Manion, Sharon Whiting, et al.. (2005). A survey of behavior problems in children with epilepsy. Epilepsy & Behavior. 6(4). 581–586. 41 indexed citations
9.
Campbell, Craig & Pierre Jacob. (2003). Deflazacort for the treatment of Duchenne Dystrophy: A systematic review. BMC Neurology. 3(1). 7–7. 48 indexed citations
10.
Pranzatelli, Michael R., Elizabeth D. Tate, Nancy Bass, et al.. (2002). Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia. Pediatric Neurology. 27(5). 384–387. 37 indexed citations
11.
Keene, Daniel L., et al.. (2001). Cerebral vascular events associated with ulcerative colitis in children. Pediatric Neurology. 24(3). 238–243. 25 indexed citations
12.
Keene, Daniel L., et al.. (1999). Ketogenic diet in the treatment of refractory epilepsy in childhood. Pediatric Neurology. 21(2). 548–552. 77 indexed citations
13.
Lucotte, G, et al.. (1995). Molecular characterization of Charcot-Marie-Tooth patients in 15 pedigrees from France.. PubMed. 6(4). 355–60. 2 indexed citations
14.
MacKenzie, Alex, et al.. (1994). Genetic heterogeneity in spinal muscular atrophy. Neurology. 44(5). 919–919. 12 indexed citations
15.
McLean, Mark, Philippe Duclos, Pierre Jacob, & Peter Humphreys. (1994). Incidence of Guillain-Barre Syndrome in Ontario and Quebec, 1983–1989, Using Hospital Service Databases. Epidemiology. 5(4). 443–448. 48 indexed citations
16.
Hunter, Alasdair G. W., Pierre Jacob, Kim O'Hoy, et al.. (1993). Decrease in the size of the myotonic dystrophy CTG repeat during transmission from parent to child: Implications for genetic counselling and genetic anticipation. American Journal of Medical Genetics. 45(3). 401–407. 29 indexed citations
17.
MacKenzie, Alex, Natalie Roy, Gabrielle Mettler, et al.. (1993). Genetic linkage analysis of Canadian spinal muscular atrophy kindreds using flanking microsatellite 5q13 polymorphisms. Human Genetics. 90(5). 16 indexed citations
18.
Maublant, Jean C., X. Marcaggi, Jean‐René Lusson, et al.. (1992). Comparison between thallium-201 and technetium-99m methoxyisobutyl isonitrile defect size in single-photon emission computed tomography at rest, exercise and redistribution in coronary artery disease. The American Journal of Cardiology. 69(3). 183–187. 28 indexed citations
19.
Korneluk, Robert G., A.E. MacKenzie, Yoshihiko Nakamura, et al.. (1989). A reordering of human chromosome 19 long-arm DNA markers and identification of markers flanking the myotonic dystrophy locus. Genomics. 5(3). 596–604. 51 indexed citations
20.
McGrath, Patrick J., Peter Humphreys, John T. Goodman, et al.. (1988). RELAXATION PROPHYLAXIS FOR CHILDHOOD MIGRAINE: A RANDOMIZED PLACEBO‐CONTROLLED TRIAL. Developmental Medicine & Child Neurology. 30(5). 626–631. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig Campbell Breakdown of academic impact, for papers by Paula Bray Breakdown of academic impact, for papers by Henry B. Wessel Breakdown of academic impact, for papers by Martin Kirkpatrick Breakdown of academic impact, for papers by Sotiris Youroukos Breakdown of academic impact, for papers by Christian von der Brelie Breakdown of academic impact, for papers by John H. N. Deck Breakdown of academic impact, for papers by Pierre J. Vinken Breakdown of academic impact, for papers by Raphael Weitz Breakdown of academic impact, for papers by Federica Zibordi
Rankless by CCL
2026